Logo image of KBAL

KIMBALL INTERNATIONAL-B (KBAL) Stock Fundamental Analysis

NASDAQ:KBAL - Nasdaq - US4942741038 - Common Stock - Currency: USD

12.3  -0.11 (-0.89%)

After market: 12.3 0 (0%)

Fundamental Rating

5

Taking everything into account, KBAL scores 5 out of 10 in our fundamental rating. KBAL was compared to 84 industry peers in the Commercial Services & Supplies industry. KBAL has only an average score on both its financial health and profitability. KBAL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

KBAL had positive earnings in the past year.
In the past year KBAL had a positive cash flow from operations.
KBAL had positive earnings in 4 of the past 5 years.
Of the past 5 years KBAL 4 years had a positive operating cash flow.
KBAL Yearly Net Income VS EBIT VS OCF VS FCFKBAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M

1.2 Ratios

The profitability ratios for KBAL are negative, so there is not much use analyzing them.
With an excellent Return On Invested Capital value of 10.38%, KBAL belongs to the best of the industry, outperforming 88.61% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for KBAL is in line with the industry average of 10.12%.
The 3 year average ROIC (9.85%) for KBAL is below the current ROIC(10.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 10.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)13.21%
KBAL Yearly ROA, ROE, ROICKBAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 5 -5 10 15 20

1.3 Margins

With a Operating Margin value of 4.85%, KBAL perfoms like the industry average, outperforming 56.96% of the companies in the same industry.
In the last couple of years the Operating Margin of KBAL has declined.
With a decent Gross Margin value of 35.35%, KBAL is doing good in the industry, outperforming 68.35% of the companies in the same industry.
In the last couple of years the Gross Margin of KBAL has remained more or less at the same level.
Industry RankSector Rank
OM 4.85%
PM (TTM) N/A
GM 35.35%
OM growth 3Y-11.23%
OM growth 5Y-10.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.44%
GM growth 5Y-0.98%
KBAL Yearly Profit, Operating, Gross MarginsKBAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KBAL is still creating some value.
KBAL has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, KBAL has a worse debt to assets ratio.
KBAL Yearly Shares OutstandingKBAL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
KBAL Yearly Total Debt VS Total AssetsKBAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

KBAL has an Altman-Z score of 4.48. This indicates that KBAL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.48, KBAL belongs to the best of the industry, outperforming 83.54% of the companies in the same industry.
KBAL has a debt to FCF ratio of 1.58. This is a very positive value and a sign of high solvency as it would only need 1.58 years to pay back of all of its debts.
KBAL has a better Debt to FCF ratio (1.58) than 89.87% of its industry peers.
KBAL has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of KBAL (0.28) is better than 62.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.58
Altman-Z 4.48
ROIC/WACC1.35
WACC7.69%
KBAL Yearly LT Debt VS Equity VS FCFKBAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

KBAL has a Current Ratio of 1.41. This is a normal value and indicates that KBAL is financially healthy and should not expect problems in meeting its short term obligations.
KBAL has a Current ratio of 1.41. This is comparable to the rest of the industry: KBAL outperforms 51.90% of its industry peers.
KBAL has a Quick Ratio of 1.41. This is a bad value and indicates that KBAL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of KBAL (0.68) is worse than 79.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.68
KBAL Yearly Current Assets VS Current LiabilitesKBAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

4

3. Growth

3.1 Past

KBAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 476.92%, which is quite impressive.
KBAL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.83%.
Measured over the past years, KBAL shows a decrease in Revenue. The Revenue has been decreasing by -0.12% on average per year.
EPS 1Y (TTM)476.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)10.83%
Revenue growth 3Y-4.65%
Revenue growth 5Y-0.12%
Sales Q2Q%-8.14%

3.2 Future

The Earnings Per Share is expected to grow by 49.23% on average over the next years. This is a very strong growth
Based on estimates for the next years, KBAL will show a small growth in Revenue. The Revenue will grow by 5.01% on average per year.
EPS Next Y65.61%
EPS Next 2Y59.52%
EPS Next 3Y49.23%
EPS Next 5YN/A
Revenue Next Year7.75%
Revenue Next 2Y7.05%
Revenue Next 3Y5.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KBAL Yearly Revenue VS EstimatesKBAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
KBAL Yearly EPS VS EstimatesKBAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.40, which indicates a correct valuation of KBAL.
Based on the Price/Earnings ratio, KBAL is valued a bit cheaper than the industry average as 72.15% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 29.62, KBAL is valued a bit cheaper.
With a Price/Forward Earnings ratio of 15.59, KBAL is valued correctly.
Based on the Price/Forward Earnings ratio, KBAL is valued a bit cheaper than the industry average as 67.09% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, KBAL is valued a bit cheaper.
Industry RankSector Rank
PE 16.4
Fwd PE 15.59
KBAL Price Earnings VS Forward Price EarningsKBAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KBAL is valued a bit cheaper than the industry average as 74.68% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, KBAL is valued cheaper than 82.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.2
EV/EBITDA 8.26
KBAL Per share dataKBAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KBAL's earnings are expected to grow with 49.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y59.52%
EPS Next 3Y49.23%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.93%, KBAL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.14, KBAL pays a better dividend. On top of this KBAL pays more dividend than 86.08% of the companies listed in the same industry.
KBAL's Dividend Yield is a higher than the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.93%

5.2 History

The dividend of KBAL is nicely growing with an annual growth rate of 8.82%!
KBAL has paid a dividend for at least 10 years, which is a reliable track record.
As KBAL did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)8.82%
Div Incr Years0
Div Non Decr Years8
KBAL Yearly Dividends per shareKBAL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.1 0.2 0.3

5.3 Sustainability

KBAL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
KBAL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-67.9%
EPS Next 2Y59.52%
EPS Next 3Y49.23%
KBAL Yearly Income VS Free CF VS DividendKBAL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M

KIMBALL INTERNATIONAL-B

NASDAQ:KBAL (5/31/2023, 8:27:41 PM)

After market: 12.3 0 (0%)

12.3

-0.11 (-0.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-04 2023-05-04/amc
Earnings (Next)08-02 2023-08-02/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners4.4%
Ins Owner Change0%
Market Cap448.59M
Analysts82.86
Price Target12.92 (5.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.93%
Yearly Dividend0.36
Dividend Growth(5Y)8.82%
DP-67.9%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)821.39%
Min EPS beat(2)-21.57%
Max EPS beat(2)1664.35%
EPS beat(4)3
Avg EPS beat(4)440.72%
Min EPS beat(4)-21.57%
Max EPS beat(4)1664.35%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.26%
Min Revenue beat(2)0.67%
Max Revenue beat(2)1.85%
Revenue beat(4)2
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-5.05%
Max Revenue beat(4)1.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)22.89%
EPS NQ rev (3m)22.89%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-7.09%
Revenue NQ rev (3m)-7.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.4
Fwd PE 15.59
P/S 0.64
P/FCF 14.2
P/OCF 7.74
P/B 2.5
P/tB 3.83
EV/EBITDA 8.26
EPS(TTM)0.75
EY6.1%
EPS(NY)0.79
Fwd EY6.41%
FCF(TTM)0.87
FCFY7.04%
OCF(TTM)1.59
OCFY12.93%
SpS19.3
BVpS4.92
TBVpS3.21
PEG (NY)0.25
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 10.38%
ROICexc 11.19%
ROICexgc 15.1%
OM 4.85%
PM (TTM) N/A
GM 35.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)13.21%
ROICexc(3y)13.27%
ROICexc(5y)20.96%
ROICexgc(3y)17.43%
ROICexgc(5y)26.33%
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-31.94%
ROICexcg growth 5Y-23.57%
ROICexc growth 3Y-36.65%
ROICexc growth 5Y-29.3%
OM growth 3Y-11.23%
OM growth 5Y-10.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.44%
GM growth 5Y-0.98%
F-Score6
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.58
Debt/EBITDA 0.86
Cap/Depr 110.36%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.68
Altman-Z 4.48
F-Score6
WACC7.69%
ROIC/WACC1.35
Cap/Depr(3y)105.63%
Cap/Depr(5y)117.45%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)476.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y65.61%
EPS Next 2Y59.52%
EPS Next 3Y49.23%
EPS Next 5YN/A
Revenue 1Y (TTM)10.83%
Revenue growth 3Y-4.65%
Revenue growth 5Y-0.12%
Sales Q2Q%-8.14%
Revenue Next Year7.75%
Revenue Next 2Y7.05%
Revenue Next 3Y5.01%
Revenue Next 5YN/A
EBIT growth 1Y11.34%
EBIT growth 3Y-15.35%
EBIT growth 5Y-11.05%
EBIT Next Year385.81%
EBIT Next 3Y88.73%
EBIT Next 5YN/A
FCF growth 1Y32.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.08%
OCF growth 3YN/A
OCF growth 5YN/A